Basilea berichtet auf ASCO Gastrointestinal Cancers Symposium über Aktivität von Derazantinib in präklinischen Magenkrebs-Modellen

Ads

You May Also Like

FIT Biotech Oy: EHVA clinical trial authorization granted for testing FIT-06 in UK

FIT Biotech Oy                                                             Company release 26.6.2018 at 8:30 AM EET EHVA clinical trial authorization ...